It is with great excitement that ISoP has joined forces with the Drug Safety Research Unit in Southampton to organise our yearly Mid-Year Symposium. This event will be conducted online on May 10 and May 11. Read more
Recommendations include: creating a culture where PV is prioritised, engagement / empowerment of communities to report harms, systems / infrastructural development, & learning within / between countries Read more
The guidance aims to address remaining challenges & practice gaps regarding patient involvement through the life cycle of pharmaceutical products, to improve the health of individuals & the public. Read more
A collection of videos from experts in the field of Data Monitoring Committees Read more
Open access paper reviewing changes in safety surveillance, recent scientific advances, & arguing how they need to be harnessed to enhance pharmacovigilance Read more
The Smart Safety Surveillance (3S) concept is based on the understanding that, when faced with competing pharmacovigilance priorities, countries will have to invest judiciously, by focusing on new priority products, sharing work and resources with other countries when possible and ... Read more
Supporting congenital anomaly surveillance - access upcoming & previous webinars on the Global Birth Defects hub website Read more
Bluprint developed through a step-wise consensus process to define the strategic priorities & objectives for vaccines safety for 2021 to 2023 & beyond Read more
CIOMS has produced a living glossary (first published 2021), compiling definitions from its reports on various topics in the field of pharmacovigilance Read more
Can't find what you're looking for? Try browsing our Featured News Sources. You can also find new previously featured on our home page in our News Archive! Read more
This module from the Toolkit for research and development of paediatric antiretroviral drugs and formulations introduces the concepts of pharmacovigilance and adverse drug reactions, discusses the burden of adverse drug reactions for children and explains the importance of pharmacovigilance in the context of antiretroviral therapy.
The problem of substandard and falsified (SF) medical products affects all countries but few regulatory authorities or pharmaceutical companies have policies of publicly releasing data. In order to fill the ...